InventisBio Co., Limited (SHA:688382)

China · Delayed Price · Currency is CNY

19.99

+2.08 (11.61%)

Mar 27, 2026, 4:00 PM EDT

Revenue by Segment

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018
Research and Development of Drugs and Other Businesses	37.33M	168.79M	185.53M	-			55.30M
Research and Development of Drugs and Other Businesses Growth	-77.89%	-9.02%	-	-			-
Total	37.33M	168.79M	185.53M	-			55.30M
Total Growth	-77.89%	-9.02%	-	-			-

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018
China	37.33M	168.79M	185.53M	-			55.30M
China Growth	-77.89%	-9.02%	-	-			-
Total	37.33M	168.79M	185.53M	-			55.30M
Total Growth	-77.89%	-9.02%	-	-			-

Source: S&P Global Market Intelligence.